GlobalData has compiled a summary of clinical trials in New Zealand. GlobalData captured records of 1,016 clinical trials across all diseases and phases that had a start date between 1 January 2012 and 31 December 2016.

In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively. Overall, Phase III trials outnumbered all other trials, making up 40–48% of the trial types across the period. The share of Phase II trials was second, ranging from 24–39%, and hitting its lowest percentage in 2014, as shown in Figure 1. The share of Phase I trials increased from 10% up to 26% over the five-year period, while Phase IV trials decreased from 13% in 2012 to 5% in 2016.

Figure 1: clinical trials in New Zealand by phase, 2012-2016

Source: GlobalData Pharma Intelligence Center, Clinical Trials Database [Accessed December, 2017]

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.